Quintavalle, Cristina <br/><br/>
Phosphoprotein enriched in diabetes (PED/PEA15) promotes migration in hepatocellular carcinoma and confers resistance to sorafenib.  [electronic resource] 

 -  Cell death & disease  10 2017 
 - e3138 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2041-4889 
<br/><br/><label>Standard No.: </label>10.1038/cddis.2017.512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Apoptosis Regulatory Proteins<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Child<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Intracellular Signaling Peptides and Proteins--genetics<br/>Liver Neoplasms--drug therapy<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Phenylurea Compounds--administration & dosage<br/>Phosphoproteins--genetics<br/>Sorafenib<br/>Transfection<br/>Young Adult